Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Eli Lilly & Co (LLY) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Eli Lilly & Co. Table 2 shows the detailed insider transactions. This company's CIK number is 59478.
Total stock buying since 2015: $8,218,370.
Total stock sales since 2015: $23,196,371,694.
Total stock option exercises since 2015: $14,061,172.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 6,987 | $4,537,241 | 1,163,250 | $4,554,322,244 | 17,390 | $0 |
| 2024 | 0 | $0 | 2,879,232 | $2,352,513,879 | 16,479 | $0 |
| 2023 | 0 | $0 | 3,210,312 | $11,902,712,132 | 128,773 | $0 |
| 2022 | 858 | $249,397 | 4,522,320 | $1,397,922,981 | 66,315 | $0 |
| 2021 | 1,366 | $249,793 | 3,428,533 | $800,353,310 | 168,003 | $0 |
| 2020 | 0 | $0 | 3,592,018 | $542,331,593 | 120,374 | $0 |
| 2019 | 14,016 | $1,522,398 | 3,603,616 | $436,202,568 | 78,579 | $0 |
| 2018 | 12,168 | $1,068,636 | 5,179,358 | $521,807,695 | 261,952 | $0 |
| 2017 | 0 | $0 | 2,407,515 | $200,673,199 | 183,310 | $0 |
| 2016 | 7,605 | $590,905 | 2,352,371 | $183,183,419 | 201,412 | $0 |
| 2015 | 0 | $0 | 3,775,670 | $304,348,674 | 433,658 | $14,061,172 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 6,987 | $4,537,241 | 2,250 | $1,518,692 | 952 | $0 |
| 2025-07 | 0 | $0 | 280,000 | $225,667,400 | 0 | $0 |
| 2025-05 | 0 | $0 | 1,000 | $716,410 | 0 | $0 |
| 2025-03 | 0 | $0 | 220,000 | $204,316,640 | 5,240 | $0 |
| 2025-02 | 0 | $0 | 660,000 | $4,122,103,102 | 11,198 | $0 |
| 2024-11 | 0 | $0 | 900 | $723,042 | 4,295 | $0 |
| 2024-09 | 0 | $0 | 24,084 | $23,307,074 | 0 | $0 |
| 2024-08 | 0 | $0 | 28,498 | $27,603,560 | 0 | $0 |
| 2024-07 | 0 | $0 | 423,559 | $393,731,235 | 0 | $0 |
| 2024-06 | 0 | $0 | 1,034,235 | $894,723,652 | 0 | $0 |
| 2024-05 | 0 | $0 | 497,206 | $403,033,781 | 0 | $0 |
| 2024-03 | 0 | $0 | 750 | $565,200 | 0 | $0 |
| 2024-02 | 0 | $0 | 435,000 | $330,149,743 | 12,184 | $0 |
| 2024-01 | 0 | $0 | 435,000 | $278,676,592 | 0 | $0 |
| 2023-12 | 0 | $0 | 0 | $0 | 4,810 | $0 |
| 2023-11 | 0 | $0 | 670 | $382,637 | 0 | $0 |
| 2023-10 | 0 | $0 | 215,000 | $130,184,220 | 0 | $0 |
| 2023-09 | 0 | $0 | 211,148 | $120,424,645 | 0 | $0 |
| 2023-08 | 0 | $0 | 835,009 | $10,871,707,100 | 0 | $0 |
| 2023-07 | 0 | $0 | 591 | $275,773 | 0 | $0 |
| 2023-06 | 0 | $0 | 466,294 | $214,673,496 | 18,900 | $0 |
| 2023-05 | 0 | $0 | 435,600 | $188,760,883 | 0 | $0 |
| 2023-04 | 0 | $0 | 635,000 | $236,769,683 | 0 | $0 |
| 2023-03 | 0 | $0 | 406,000 | $137,810,620 | 5,271 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-28 | Zakrowski Donald A (SVP, Finance, & CAO) | Sale | 1,000 | 734.93 | 734,930 |
| 2025-08-15 | Montarce Lucas (EVP & CFO) | Buy | 715 | 691.79 | 494,626 |
| 2025-08-13 | Van Naarden Jacob (EVP & Pres., Lilly Oncology) | Buy | 1,000 | 647.36 | 647,360 |
| 2025-08-13 | Alvarez Ralph (Director) | Buy | 758 | 660.25 | 500,472 |
| 2025-08-12 | Skovronsky Daniel (EVP, CSO & Pres. LRL & LLY Imm) | Buy | 1,000 | 634.40 | 634,405 |
| 2025-08-12 | Ricks David A (President, Chair, and CEO) | Buy | 1,632 | 644.77 | 1,052,263 |
| 2025-08-12 | Fyrwald J Erik (Director) | Buy | 1,565 | 642.29 | 1,005,185 |
| 2025-08-12 | Sulzberger Gabrielle (Director) | Buy | 117 | 641.18 | 75,018 |
| 2025-08-11 | Yuffa Ilya (EVP&Pres, LLY USA&Global Capab) | Sale | 1,250 | 627.01 | 783,762 |
| 2025-08-08 | Jackson Jamere (Director) | Buy | 200 | 639.56 | 127,912 |
| 2025-08-01 | Seymour Melissa (EVP, Global Quality) | Option Ex | 952 | .00 | 0 |
| 2025-07-24 | Lilly Endowment Inc | Sale | 280,000 | 805.96 | 225,667,400 |
| 2025-05-27 | Zakrowski Donald A (SVP, Finance, & CAO) | Sale | 1,000 | 716.41 | 716,410 |
| 2025-03-03 | Lilly Endowment Inc | Sale | 220,000 | 928.71 | 204,316,640 |
| 2025-03-01 | Dozier Eric (EVP, Chief People Officer) | Option Ex | 2,403 | .00 | 0 |
| 2025-03-01 | Hernandez Edgardo (EVP & Pres., Mfg. Operations) | Option Ex | 2,837 | .00 | 0 |
| 2025-02-25 | Lilly Endowment Inc | Sale | 225,000 | 905.96 | 203,840,550 |
| 2025-02-24 | Lilly Endowment Inc | Sale | 60,432 | 59,386.22 | 3,588,827,986 |
| 2025-02-21 | Lilly Endowment Inc | Sale | 99,452 | 885.59 | 88,073,398 |
| 2025-02-20 | Lilly Endowment Inc | Sale | 14,685 | 878.84 | 12,905,780 |
| 2025-02-19 | Lilly Endowment Inc | Sale | 9,985 | 878.96 | 8,776,375 |
| 2025-02-13 | Lilly Endowment Inc | Sale | 35,446 | 880.55 | 31,211,833 |
| 2025-02-10 | Skovronsky Daniel (EVP, CSO & Pres. LRL & LLY Imm) | Sale | 5,000 | 864.14 | 4,320,700 |
| 2025-02-06 | Lilly Endowment Inc | Sale | 210,000 | 876.89 | 184,146,480 |
| 2025-02-01 | Hernandez Edgardo (EVP & Pres., Mfg. Operations) | Option Ex | 2,861 | .00 | 0 |
| 2025-02-01 | Jonsson Patrik (EVP&Pres, CardMetHlth, LLY USA) | Option Ex | 3,433 | .00 | 0 |
| 2025-02-01 | Hakim Anat (EVP, GC & Secretary) | Option Ex | 4,904 | .00 | 0 |
| 2024-11-08 | Zakrowski Donald A (SVP, Finance, & CAO) | Sale | 900 | 803.38 | 723,042 |
| 2024-11-01 | Dozier Eric (EVP, HR & Diversity) | Option Ex | 1,534 | .00 | 0 |
| 2024-11-01 | Hernandez Edgardo (EVP & Pres., Mfg. Operations) | Option Ex | 1,687 | .00 | 0 |
| 2024-11-01 | Montarce Lucas (EVP & CFO) | Option Ex | 1,074 | .00 | 0 |
| 2024-09-03 | Lilly Endowment Inc | Sale | 24,084 | 967.74 | 23,307,074 |
| 2024-08-27 | Lilly Endowment Inc | Sale | 24,552 | 969.44 | 23,801,666 |
| 2024-08-26 | Zakrowski Donald A (SVP, Finance, & CAO) | Sale | 750 | 950.00 | 712,500 |
| 2024-08-22 | Lilly Endowment Inc | Sale | 3,196 | 966.64 | 3,089,394 |
| 2024-07-10 | Lilly Endowment Inc | Sale | 210,000 | 940.99 | 197,607,060 |
| 2024-07-08 | Lilly Endowment Inc | Sale | 93,593 | 921.69 | 86,263,732 |
| 2024-07-05 | Lilly Endowment Inc | Sale | 52,369 | 915.70 | 47,954,083 |
| 2024-07-03 | Lilly Endowment Inc | Sale | 8,848 | 916.36 | 8,107,962 |
| 2024-07-01 | Lilly Endowment Inc | Sale | 58,749 | 915.73 | 53,798,398 |
| 2024-06-28 | Lilly Endowment Inc | Sale | 1,441 | 915.02 | 1,318,545 |
| 2024-06-25 | Lilly Endowment Inc | Sale | 188,100 | 905.89 | 170,397,344 |
| 2024-06-24 | Lilly Endowment Inc | Sale | 17,229 | 902.86 | 15,555,357 |
| 2024-06-20 | Lilly Endowment Inc | Sale | 9,671 | 903.33 | 8,736,133 |
| 2024-06-17 | Lilly Endowment Inc | Sale | 194,978 | 887.47 | 173,036,735 |
| 2024-06-14 | Lilly Endowment Inc | Sale | 15,022 | 882.83 | 13,261,827 |
| 2024-06-10 | Lilly Endowment Inc | Sale | 75,510 | 861.15 | 65,025,436 |
| 2024-06-07 | Lilly Endowment Inc | Sale | 139,490 | 853.93 | 119,115,393 |
| 2024-06-06 | Lilly Endowment Inc | Sale | 179,617 | 841.48 | 151,144,831 |
| 2024-06-05 | Lilly Endowment Inc | Sale | 20,383 | 836.90 | 17,058,471 |
| 2024-06-03 | Lilly Endowment Inc | Sale | 192,794 | 830.28 | 160,073,580 |
| 2024-05-31 | Lilly Endowment Inc | Sale | 22,206 | 822.63 | 18,267,321 |
| 2024-05-29 | Lilly Endowment Inc | Sale | 130,385 | 812.44 | 105,930,250 |
| 2024-05-28 | Lilly Endowment Inc | Sale | 2,052 | 809.00 | 1,660,068 |
| 2024-05-24 | Lilly Endowment Inc | Sale | 92,563 | 809.21 | 74,902,997 |
| 2024-05-23 | Lilly Endowment Inc | Sale | 50,767 | 812.27 | 41,236,409 |
| 2024-05-22 | Lilly Endowment Inc | Sale | 12,974 | 804.18 | 10,433,483 |
| 2024-05-21 | Lilly Endowment Inc | Sale | 186,259 | 808.57 | 150,603,253 |
| 2024-03-11 | Zakrowski Donald A (SVP, Finance, & CAO) | Sale | 750 | 753.60 | 565,200 |
| 2024-02-16 | Lilly Endowment Inc | Sale | 169,684 | 778.80 | 132,149,220 |
| 2024-02-15 | Lilly Endowment Inc | Sale | 50,316 | 761.34 | 38,307,432 |
| 2024-02-09 | Lilly Endowment Inc | Sale | 206,257 | 742.87 | 153,222,756 |
| 2024-02-08 | Lilly Endowment Inc | Sale | 8,743 | 740.06 | 6,470,335 |
| 2024-02-01 | White Anne E. (EVP & Pres, Lilly Neuroscience) | Option Ex | 4,124 | .00 | 0 |
| 2024-02-01 | Hakim Anat (EVP, GC & Secretary) | Option Ex | 4,442 | .00 | 0 |
| 2024-02-01 | Van Naarden Jacob (EVP & Pres., Loxo@Lilly) | Option Ex | 3,618 | .00 | 0 |
| 2024-01-31 | Lilly Endowment Inc | Sale | 78,573 | 654.18 | 51,401,199 |
| 2024-01-30 | Lilly Endowment Inc | Sale | 76,215 | 645.69 | 49,211,339 |
| 2024-01-29 | Lilly Endowment Inc | Sale | 54,032 | 645.07 | 34,854,422 |
| 2024-01-16 | Lilly Endowment Inc | Sale | 1,180 | 645.86 | 762,112 |
| 2024-01-11 | Lilly Endowment Inc | Sale | 12,344 | 634.46 | 7,831,737 |
| 2024-01-10 | Lilly Endowment Inc | Sale | 163,730 | 633.44 | 103,713,622 |
| 2024-01-09 | Lilly Endowment Inc | Sale | 34,538 | 632.01 | 21,828,326 |
| 2024-01-04 | Lilly Endowment Inc | Sale | 14,388 | 630.65 | 9,073,835 |
| 2023-12-01 | Zakrowski Donald A (SVP, Finance, & CAO) | Option Ex | 4,810 | .00 | 0 |
| 2023-11-06 | Zakrowski Donald A (SVP, Finance, & CAO) | Sale | 670 | 571.10 | 382,637 |
| 2023-10-11 | Lilly Endowment Inc | Sale | 215,000 | 605.51 | 130,184,220 |
| 2023-09-12 | Weems Alonzo (EVP, ERM & CECO) | Sale | 1,148 | 590.98 | 678,445 |
| 2023-09-07 | Lilly Endowment Inc | Sale | 210,000 | 570.22 | 119,746,200 |
| 2023-08-31 | Lilly Endowment Inc | Sale | 46,541 | 555.88 | 25,870,978 |
| 2023-08-30 | Lilly Endowment Inc | Sale | 6,181 | 555.73 | 3,434,991 |
| 2023-08-29 | Lilly Endowment Inc | Sale | 28,747 | 554.97 | 15,953,607 |
| 2023-08-28 | Lilly Endowment Inc | Sale | 37,660 | 277,328.27 | 10,444,182,648 |
| 2023-08-25 | Lilly Endowment Inc | Sale | 63,572 | 555.22 | 35,296,572 |
| 2023-08-24 | Lilly Endowment Inc | Sale | 20,992 | 555.47 | 11,660,468 |
| 2023-08-23 | Lilly Endowment Inc | Sale | 1,307 | 555.69 | 726,284 |
| 2023-08-21 | Zakrowski Donald A (SVP, Finance, & CAO) | Sale | 600 | 546.51 | 327,906 |
| 2023-08-15 | Lilly Endowment Inc | Sale | 50,222 | 542.80 | 27,260,702 |
| 2023-08-14 | Lilly Endowment Inc | Sale | 164,778 | 540.40 | 89,045,701 |
| 2023-08-11 | Lilly Endowment Inc | Sale | 83,039 | 529.81 | 43,995,141 |
| 2023-08-10 | Lilly Endowment Inc | Sale | 3,000 | 528.13 | 1,584,405 |
| 2023-08-09 | Lilly Endowment Inc | Sale | 123,961 | 530.36 | 65,744,079 |
| 2023-08-08 | Lilly Endowment Inc | Sale | 204,409 | 521.62 | 106,623,618 |
| 2023-07-21 | Lilly Endowment Inc | Sale | 591 | 466.62 | 275,773 |
| 2023-06-30 | Lilly Endowment Inc (10% Owner) | Sale | 164,125 | 467.45 | 76,721,051 |
| 2023-06-29 | Lilly Endowment Inc (10% Owner) | Sale | 44,115 | 465.08 | 20,517,136 |
| 2023-06-28 | Lilly Endowment Inc (10% Owner) | Sale | 11,760 | 465.78 | 5,477,561 |
| 2023-06-22 | Lilly Endowment Inc (10% Owner) | Sale | 107,022 | 458.99 | 49,121,599 |
| 2023-06-21 | Lilly Endowment Inc (10% Owner) | Sale | 31,454 | 454.54 | 14,297,101 |
| 2023-06-20 | Lilly Endowment Inc (10% Owner) | Sale | 34,156 | 454.08 | 15,509,556 |
| 2023-06-16 | Lilly Endowment Inc (10% Owner) | Sale | 25,015 | 455.53 | 11,395,157 |
| 2023-06-15 | Norton Johna (EVP, Global Quality) | Sale | 1,647 | 448.00 | 737,856 |
| 2023-06-15 | Lilly Endowment Inc (10% Owner) | Sale | 27,353 | 454.59 | 12,434,454 |
| 2023-06-14 | Norton Johna (EVP, Global Quality) | Sale | 1,647 | 444.29 | 731,745 |
| 2023-06-01 | Rau Diogo (EVP & CIDO) | Option Ex | 12,600 | .00 | 0 |
| 2023-06-01 | Jonsson Patrik (EVP&Pres, LLY Imm, LLY USA&CCO) | Sale | 12,000 | 429.46 | 5,153,520 |
| 2023-05-19 | Lilly Endowment Inc (10% Owner) | Sale | 194,354 | 444.92 | 86,471,398 |
| 2023-05-15 | Zakrowski Donald A (SVP, Finance, & CAO) | Sale | 600 | 435.29 | 261,174 |
| 2023-05-12 | Lilly Endowment Inc (10% Owner) | Sale | 20,646 | 443.29 | 9,152,144 |
| 2023-05-03 | Lilly Endowment Inc (10% Owner) | Sale | 178,302 | 425.09 | 75,794,040 |
| 2023-05-02 | Lilly Endowment Inc (10% Owner) | Sale | 41,698 | 409.66 | 17,082,127 |
| 2023-04-28 | Lilly Endowment Inc (10% Owner) | Sale | 225,000 | 399.57 | 89,903,700 |
| 2023-04-06 | Lilly Endowment Inc (10% Owner) | Sale | 130,297 | 367.21 | 47,846,100 |
| 2023-04-05 | Lilly Endowment Inc (10% Owner) | Sale | 69,703 | 363.73 | 25,352,723 |
| 2023-04-03 | Lilly Endowment Inc (10% Owner) | Sale | 210,000 | 350.80 | 73,667,160 |
| 2023-03-31 | Lilly Endowment Inc (10% Owner) | Sale | 205,000 | 342.71 | 70,256,370 |
| 2023-03-24 | Lilly Endowment Inc (10% Owner) | Sale | 200,000 | 336.18 | 67,235,400 |
| 2023-03-10 | Weems Alonzo (EVP, ERM & CECO) | Sale | 1,000 | 318.85 | 318,850 |
| 2023-03-01 | Dozier Eric (EVP, HR & Diversity) | Option Ex | 1,602 | .00 | 0 |
| 2023-03-01 | Weems Alonzo (EVP, ERM & CECO) | Option Ex | 1,779 | .00 | 0 |
| 2023-03-01 | Hernandez Edgardo (EVP & Pres., Mfg. Operations) | Option Ex | 1,890 | .00 | 0 |
| 2023-02-16 | Van Naarden Jacob (EVP and CEO Loxo@Lilly) | Option Ex | 2,785 | .00 | 0 |
| 2023-02-13 | White Anne E. (EVP & Pres, Lilly Neuroscience) | Sale | 2,500 | 346.47 | 866,175 |
| 2023-02-10 | White Anne E. (EVP & Pres, Lilly Neuroscience) | Sale | 2,500 | 342.76 | 856,900 |
| 2023-02-01 | Mason Michael B (EVP & Pres., Lilly Diabetes) | Option Ex | 6,690 | .00 | 0 |
| 2023-02-01 | Jonsson Patrik (EVP&Pres, LLY Imm, LLY USA&CCO) | Option Ex | 6,690 | .00 | 0 |
| 2023-02-01 | White Anne E. (EVP & Pres, Lilly Neuroscience) | Option Ex | 7,264 | .00 | 0 |
| 2023-02-01 | Skovronsky Daniel (EVP, CS&MO & Pres., LRL) | Option Ex | 15,675 | .00 | 0 |
| 2023-02-01 | Pusey Leigh Ann (EVP, Corp. Affairs & Comm.) | Option Ex | 3,154 | .00 | 0 |
| 2023-02-01 | Norton Johna (EVP, Global Quality) | Option Ex | 2,102 | .00 | 0 |
| 2023-02-01 | Hakim Anat (EVP, GC & Secretary) | Option Ex | 7,646 | .00 | 0 |
| 2023-02-01 | Ricks David A (President, Chair, and CEO) | Option Ex | 47,786 | .00 | 0 |
| 2022-12-02 | Lilly Endowment Inc (10% Owner) | Sale | 49,089 | 372.97 | 18,308,675 |
| 2022-12-01 | Lilly Endowment Inc (10% Owner) | Sale | 160,911 | 373.31 | 60,069,685 |
| 2022-11-07 | Lilly Endowment Inc (10% Owner) | Sale | 63,585 | 364.42 | 23,171,900 |
| 2022-11-04 | Lilly Endowment Inc (10% Owner) | Sale | 1,336 | 363.73 | 485,943 |
| 2022-11-03 | Lilly Endowment Inc (10% Owner) | Sale | 133,948 | 362.08 | 48,499,891 |
| 2022-11-02 | Lilly Endowment Inc (10% Owner) | Sale | 6,131 | 362.07 | 2,219,851 |
| 2022-10-21 | Lilly Endowment Inc (10% Owner) | Sale | 161,936 | 338.90 | 54,880,758 |
| 2022-10-19 | Lilly Endowment Inc (10% Owner) | Sale | 3,547 | 335.48 | 1,189,933 |
| 2022-10-18 | Lilly Endowment Inc (10% Owner) | Sale | 12,042 | 334.29 | 4,025,472 |
| 2022-10-17 | Lilly Endowment Inc (10% Owner) | Sale | 79,624 | 335.88 | 26,744,507 |
| 2022-10-14 | Lilly Endowment Inc (10% Owner) | Sale | 3,187 | 334.42 | 1,065,780 |
| 2022-10-12 | Lilly Endowment Inc (10% Owner) | Sale | 400 | 333.50 | 133,400 |
| 2022-10-10 | Weems Alonzo (EVP, ERM & CECO) | Sale | 656 | 326.23 | 214,006 |
| 2022-10-06 | Lilly Endowment Inc (10% Owner) | Sale | 149,264 | 336.56 | 50,236,142 |
| 2022-09-28 | Lilly Endowment Inc (10% Owner) | Sale | 101,631 | 336.99 | 34,248,833 |
| 2022-08-12 | Tai Jackson P | Buy | 656 | 304.19 | 199,548 |
| 2022-08-10 | Weems Alonzo (SVP, ERM & CECO) | Sale | 656 | 304.50 | 199,752 |
| 2022-07-28 | Lilly Endowment Inc (10% Owner) | Sale | 89,458 | 333.18 | 29,805,705 |
Insider trading activities including stock purchases, stock sales, and option exercises of LLY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Eli Lilly & Co (symbol LLY, CIK number 59478) see the Securities and Exchange Commission (SEC) website.